Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 4
1992 1
1993 1
1996 3
1997 5
1998 1
1999 8
2000 7
2001 3
2002 3
2003 6
2004 10
2005 7
2006 5
2007 6
2008 7
2009 12
2010 10
2011 17
2012 22
2013 19
2014 19
2015 28
2016 25
2017 24
2018 24
2019 15
2020 31
2021 29
2022 34
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

347 results
Results by year
Filters applied: . Clear all
Page 1
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Mariño Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Jean K, El Kassas M, Shousha HI, Omar A, Zavaglia C, Nagata H, Nakagawa M, Asahina Y, Singal AG, Murphy C, Kohla M, Masetti C, Dufour JF, Merchante N, Cavalletto L, Chemello LL, Pol S, Crespo J, Calleja JL, Villani R, Serviddio G, Zanetto A, Shalaby S, Russo FP, Bielen R, Trevisani F, Cammà C, Bruix J, Cabibbo G, Reig M. Sapena V, et al. Among authors: camma c. Gut. 2022 Mar;71(3):593-604. doi: 10.1136/gutjnl-2020-323663. Epub 2021 Mar 19. Gut. 2022. PMID: 33741640
Reply.
Vizzutti F, Celsa C, Battaglia S, Miraglia R, Enea M, Marra F, Caporali C, Cammà C, Schepis F. Vizzutti F, et al. Among authors: camma c. Hepatology. 2023 Apr 1;77(4):E76-E77. doi: 10.1002/hep.32813. Epub 2022 Oct 12. Hepatology. 2023. PMID: 36177688 No abstract available.
Reply.
Vizzutti F, Celsa C, Battaglia S, Miraglia R, Enea M, Marra F, Colecchia A, Cammà C, Schepis F. Vizzutti F, et al. Among authors: camma c. Hepatology. 2023 Mar 1;77(3):E57-E58. doi: 10.1002/hep.32784. Epub 2023 Feb 17. Hepatology. 2023. PMID: 36098577 No abstract available.
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials.
Cabibbo G, Reig M, Celsa C, Torres F, Battaglia S, Enea M, Rizzo GEM, Petta S, Calvaruso V, Di Marco V, Craxì A, Singal AG, Bruix J, Cammà C. Cabibbo G, et al. Among authors: camma c. Liver Cancer. 2021 Nov 23;11(1):75-84. doi: 10.1159/000520278. eCollection 2022 Jan. Liver Cancer. 2021. PMID: 35222509 Free PMC article.
SARS-CoV-2 in Namibian Dogs.
Molini U, Coetzee LM, Engelbrecht T, de Villiers L, de Villiers M, Mangone I, Curini V, Khaiseb S, Ancora M, Cammà C, Lorusso A, Franzo G. Molini U, et al. Among authors: camma c. Vaccines (Basel). 2022 Dec 13;10(12):2134. doi: 10.3390/vaccines10122134. Vaccines (Basel). 2022. PMID: 36560544 Free PMC article.
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
Vizzutti F, Celsa C, Calvaruso V, Enea M, Battaglia S, Turco L, Senzolo M, Nardelli S, Miraglia R, Roccarina D, Campani C, Saltini D, Caporali C, Indulti F, Gitto S, Zanetto A, Di Maria G, Bianchini M, Pecchini M, Aspite S, Di Bonaventura C, Citone M, Guasconi T, Di Benedetto F, Arena U, Fanelli F, Maruzzelli L, Riggio O, Burra P, Colecchia A, Villa E, Marra F, Cammà C, Schepis F. Vizzutti F, et al. Among authors: camma c. Hepatology. 2023 Feb 1;77(2):476-488. doi: 10.1002/hep.32704. Epub 2022 Aug 17. Hepatology. 2023. PMID: 35921493
Prevention of hepatocellular carcinoma.
Craxì A, Cammà C. Craxì A, et al. Among authors: camma c. Clin Liver Dis. 2005 May;9(2):329-46, viii. doi: 10.1016/j.cld.2004.12.008. Clin Liver Dis. 2005. PMID: 15831277 Free article. Review.
Treatment options in HBV.
Craxì A, Antonucci G, Cammà C. Craxì A, et al. Among authors: camma c. J Hepatol. 2006;44(1 Suppl):S77-83. doi: 10.1016/j.jhep.2005.11.018. Epub 2005 Nov 28. J Hepatol. 2006. PMID: 16356581 Review.
Refining sorafenib therapy: lessons from clinical practice.
Bolondi L, Craxi A, Trevisani F, Daniele B, Di Costanzo GG, Fagiuoli S, Cammà C, Bruzzi P, Danesi R, Spandonaro F, Boni C, Santoro A, Colombo M. Bolondi L, et al. Among authors: camma c. Future Oncol. 2015;11(3):449-65. doi: 10.2217/fon.14.261. Epub 2014 Oct 31. Future Oncol. 2015. PMID: 25360997 Free article. Review.
347 results